5-Lipoxygenase metabolic contributions to NSAID-induced organ toxicity

Advances in Therapy
Bruce P Burnett, Robert M Levy

Abstract

Cyclooxygenase (COX)-1, COX-2, and 5-lipoxygenase (5-LOX) enzymes produce effectors of pain and inflammation in osteoarthritis (OA) and many other diseases. All three enzymes play a key role in the metabolism of arachidonic acid (AA) to inflammatory fatty acids, which contribute to the deterioration of cartilage. AA is derived from both phospholipase A(2) (PLA(2)) conversion of cell membrane phospholipids and dietary consumption of omega-6 fatty acids. Nonsteroidal antiinflammatory drugs (NSAIDs) inhibit the COX enzymes, but show no anti-5-LOX activity to prevent the formation of leukotrienes (LTs). Cysteinyl LTs, such as LTC(4), LTD(4), LTE(4), and leukoattractive LTB(4) accumulate in several organs of mammals in response to NSAID consumption. Elevated 5-LOX-mediated AA metabolism may contribute to the side-effect profile observed for NSAIDs in OA. Current therapeutics under development, so-called "dual inhibitors" of COX and 5-LOX, show improved side-effect profiles and may represent a new option in the management of OA.

References

Oct 1, 1992·Journal of the American Society of Nephrology : JASN·K F Badr
Jan 1, 1991·Advances in Experimental Medicine and Biology·M Rola-Pleszczynski
Jul 1, 1991·Journal of Clinical Pharmacology·A Whelton, C W Hamilton
Jul 1, 1990·Journal of Neurochemistry·T Shimizu, L S Wolfe
May 1, 1990·Digestive Diseases and Sciences·J L Wallace, C M Keenan
Jun 1, 1988·The Journal of Clinical Investigation·M A RahmanM J Dunn
Sep 12, 1986·Biochimica Et Biophysica Acta·K W DreylingB M Peskar
May 1, 1995·Journal of Lipid Mediators and Cell Signalling·R Petric, A Ford-Hutchinson
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·R J GriffithsA J Milici
Nov 1, 1994·Annals of Internal Medicine·W R Henderson
May 1, 1994·Kidney International·C R AlbrightsonD E Griswold
Jan 1, 1996·International Journal of Colorectal Disease·J L Faucheron, R Parc
Jan 1, 1997·Free Radical Biology & Medicine·Y J SuzukiA Sevanian
Mar 17, 1997·The Journal of Experimental Medicine·R J GriffithsJ D McNeish
Mar 21, 1998·The Journal of Clinical Investigation·A S CowburnA P Sampson
Jun 1, 1997·Pulmonary Pharmacology & Therapeutics·W M AbrahamS Tries
May 23, 1998·The Journal of Biological Chemistry·A G SpencerW L Smith
Nov 24, 1998·Journal of Clinical Pharmacology·J I Lee, G J Burckart
Sep 7, 1999·Journal of the American Society of Nephrology : JASN·M MaccarroneA Finazzi-Agrò
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·E NoiriT Shimizu
May 29, 2000·Archives of Internal Medicine·A WheltonG S Geis
Aug 31, 2000·Annual Review of Biochemistry·W L SmithR M Garavito
Sep 12, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·R Asero
Nov 18, 2000·Chest·K S Babu, S S Salvi
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group

❮ Previous
Next ❯

Citations

Oct 24, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Urs A BoelsterliKyle S Saitta
Dec 18, 2015·Neurochemical Research·Grzegorz A CzapskiRobert P Strosznajder
Oct 2, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Letteria MinutoliDomenica Altavilla
Aug 23, 2016·JCI Insight·Liudmila L MazaleuskayaGarret A FitzGerald
Oct 30, 2016·European Journal of Pharmacology·Amanda F CidadeRicardo Menegatti
Nov 15, 2016·Expert Opinion on Investigational Drugs·Sabine GröschGerd Geisslinger
Dec 23, 2016·Medicinal Research Reviews·Catarina Pereira-LeiteSalette Reis
May 8, 2018·Nutrients·Kok-Lun Pang, Kok-Yong Chin
Oct 4, 2013·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·James F MarkworthDavid Cameron-Smith
Feb 23, 2019·Journal of Pediatric Gastroenterology and Nutrition·Marie-Pier ThibaultJean-François Beaulieu
Feb 9, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Markus WernerJana Gerstmeier
May 20, 2020·Anais Da Academia Brasileira De Ciências·Mohamed A DkhilSaleh Al-Quraishy
May 18, 2013·Journal of Applied Physiology·Abigail L Mackey
Jun 3, 2017·International Journal of Inflammation·Anthony M KyriakopoulosVasilleios Zoumpourlis
Jun 1, 2018·Oxidative Medicine and Cellular Longevity·Antonio MicaliLetteria Minutoli
Apr 26, 2019·Journal of Pediatric Gastroenterology and Nutrition·Marie-Pier ThibaultJean-François Beaulieu
Aug 6, 2020·Pharmaceutics·Eva Espinosa-CanoJulio San Román
Nov 14, 2020·International Journal of Molecular Sciences·Felipe da Costa SouzaAlison Colquhoun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.